Informatics Improving Health
contact us : site map

October 1, 2008 - National Cancer Institute of the United States Expands Use of AIM's E-Path Software

The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute (NCI) and Artificial Intelligence In Medicine Inc. (AIM) are pleased to announce a five year extension of their original 2003 agreement to install AIM's E-Path software in 207 SEER Registries and their major reporting laboratories. This extension will add 40 more hospitals to the program, as well as provide additional software for cancer research and for enhancing the security of patient records. This contract began October 1, 2008.

The SEER Program is an authoritative source of information on cancer incidence and survival in the United States. It currently collects and publishes cancer incidence and survival data from 14 population-based cancer registries and four supplemental registries covering approximately 26 percent of the US population, and has information on more than 3.8 million cancer cases. SEER purchased AIM's software to assist in coping with the steadily increasing demands for detailed, accurate cancer data.

AIM's software automates a series of manual processes:

E-Path provides seamless integration of pathology reports from laboratories to regional and state central registries. The software automatically codes and selects reportable cancer cases, and then forwards them for appropriate action, greatly improving data quality and cost efficiency.

Synoptex converts the text of pathology reports into discrete data elements and defined values that can be processed by computer, providing researchers with fast access to previously unavailable cancer data.

Positive Case Identification helps cancer registries to conform with the Federal HIPAA privacy legislation.

In business since 1983, AIM is a Canadian software engineering firm with a firm focus on cancer informatics.

For further information please contact:

Carol L. Kosary
National Cancer Institute
Division of Cancer Control & Population Sciences
6116 Executive Blvd.
Suite 504, Room 5025
Bethesda, MD USA 20892-8316
301-402-5212

Victor Brunka
Artificial Intelligence In Medicine Inc.
403 - 2 Berkeley St.
Toronto, Ontario Canada M5A 2W3
866 645-2224 ext. 227
416 594-9393 ext. 227